Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2002 Jan;72(1):12–21. doi: 10.1136/jnnp.72.1.12

Neuropsychiatry of the basal ganglia

H Ring 1, J Serra-Mestres 1
PMCID: PMC1737705  PMID: 11784818

Abstract

This review aims to relate recent findings describing the role and neural connectivity of the basal ganglia to the clinical neuropsychiatry of basal ganglia movement disorders and to the role of basal ganglia disturbances in "psychiatric"' states. Articles relating to the relevant topics were initially collected through MEDLINE and papers relating to the clinical conditions discussed were also reviewed. The anatomy and connections of the basal ganglia indicate that these structures are important links between parts of the brain that have classically been considered to be related to emotional functioning and brain regions previously considered to have largely motor functions. The basal ganglia have a role in the development and integration of psychomotor behaviours, involving motor functions, memory and attentional mechanisms, and reward processes.

Full Text

The Full Text of this article is available as a PDF (142.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarsland D., Larsen J. P., Lim N. G., Janvin C., Karlsen K., Tandberg E., Cummings J. L. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):492–496. doi: 10.1136/jnnp.67.4.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aarsland D., Tandberg E., Larsen J. P., Cummings J. L. Frequency of dementia in Parkinson disease. Arch Neurol. 1996 Jun;53(6):538–542. doi: 10.1001/archneur.1996.00550060082020. [DOI] [PubMed] [Google Scholar]
  3. Akil M., Brewer G. J. Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol. 1995;65:171–178. [PubMed] [Google Scholar]
  4. Alexander G. E., Crutcher M. D., DeLong M. R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res. 1990;85:119–146. [PubMed] [Google Scholar]
  5. Alexander G. E., DeLong M. R., Strick P. L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357–381. doi: 10.1146/annurev.ne.09.030186.002041. [DOI] [PubMed] [Google Scholar]
  6. Allain H., Schuck S., Mauduit N. Depression in Parkinson's disease. BMJ. 2000 May 13;320(7245):1287–1288. doi: 10.1136/bmj.320.7245.1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Baumann B., Bogerts B. The pathomorphology of schizophrenia and mood disorders: similarities and differences. Schizophr Res. 1999 Sep 29;39(2):141–162. doi: 10.1016/s0920-9964(99)00113-9. [DOI] [PubMed] [Google Scholar]
  8. Baumann B., Danos P., Krell D., Diekmann S., Leschinger A., Stauch R., Wurthmann C., Bernstein H. G., Bogerts B. Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci. 1999 Winter;11(1):71–78. doi: 10.1176/jnp.11.1.71. [DOI] [PubMed] [Google Scholar]
  9. Baxter L. R. Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder. J Clin Psychiatry. 1990 Feb;51 (Suppl):22–26. [PubMed] [Google Scholar]
  10. Baxter L. R., Jr, Mazziotta J. C., Pahl J. J., Grafton S. T., St George-Hyslop P., Haines J. L., Gusella J. F., Szuba M. P., Selin C. E., Guze B. H. Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. Arch Gen Psychiatry. 1992 Feb;49(2):148–154. doi: 10.1001/archpsyc.1992.01820020068009. [DOI] [PubMed] [Google Scholar]
  11. Ben-Shlomo Y. The epidemiology of Parkinson's disease. Baillieres Clin Neurol. 1997 Apr;6(1):55–68. [PubMed] [Google Scholar]
  12. Berman I., Merson A., Viegner B., Losonczy M. F., Pappas D., Green A. I. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis. 1998 Mar;186(3):150–156. doi: 10.1097/00005053-199803000-00003. [DOI] [PubMed] [Google Scholar]
  13. Breiter H. C., Rauch S. L., Kwong K. K., Baker J. R., Weisskoff R. M., Kennedy D. N., Kendrick A. D., Davis T. L., Jiang A., Cohen M. S. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry. 1996 Jul;53(7):595–606. doi: 10.1001/archpsyc.1996.01830070041008. [DOI] [PubMed] [Google Scholar]
  14. Brooks D. J., Turjanski N., Sawle G. V., Playford E. D., Lees A. J. PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome. Adv Neurol. 1992;58:227–231. [PubMed] [Google Scholar]
  15. Brown R. G., MacCarthy B. Psychiatric morbidity in patients with Parkinson's disease. Psychol Med. 1990 Feb;20(1):77–87. doi: 10.1017/s0033291700013246. [DOI] [PubMed] [Google Scholar]
  16. Busatto G. F., Kerwin R. W. Schizophrenia, psychosis, and the basal ganglia. Psychiatr Clin North Am. 1997 Dec;20(4):897–910. doi: 10.1016/s0193-953x(05)70351-8. [DOI] [PubMed] [Google Scholar]
  17. Calabresi P., Centonze D., Gubellini P., Marfia G. A., Pisani A., Sancesario G., Bernardi G. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog Neurobiol. 2000 Jun;61(3):231–265. doi: 10.1016/s0301-0082(99)00030-1. [DOI] [PubMed] [Google Scholar]
  18. Celesia G. G., Barr A. N. Psychosis and other psychiatric manifestations of levodopa therapy. Arch Neurol. 1970 Sep;23(3):193–200. doi: 10.1001/archneur.1970.00480270003001. [DOI] [PubMed] [Google Scholar]
  19. Cummings J. L., Cunningham K. Obsessive-compulsive disorder in Huntington's disease. Biol Psychiatry. 1992 Feb 1;31(3):263–270. doi: 10.1016/0006-3223(92)90049-6. [DOI] [PubMed] [Google Scholar]
  20. Cummings J. L. Depression and Parkinson's disease: a review. Am J Psychiatry. 1992 Apr;149(4):443–454. doi: 10.1176/ajp.149.4.443. [DOI] [PubMed] [Google Scholar]
  21. Cummings J. L., Masterman D. L. Depression in patients with Parkinson's disease. Int J Geriatr Psychiatry. 1999 Sep;14(9):711–718. [PubMed] [Google Scholar]
  22. Dening T. R., Berrios G. E. Wilson's disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry. 1989 Dec;46(12):1126–1134. doi: 10.1001/archpsyc.1989.01810120068011. [DOI] [PubMed] [Google Scholar]
  23. Dening T. R., Berrios G. E. Wilson's disease: a longitudinal study of psychiatric symptoms. Biol Psychiatry. 1990 Aug 1;28(3):255–265. doi: 10.1016/0006-3223(90)90581-l. [DOI] [PubMed] [Google Scholar]
  24. Deutch A. Y. Identification of the neural systems subserving the actions of clozapine: clues from immediate-early gene expression. J Clin Psychiatry. 1994 Sep;55 (Suppl B):37–42. [PubMed] [Google Scholar]
  25. Drevets W. C. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci. 1999 Jun 29;877:614–637. doi: 10.1111/j.1749-6632.1999.tb09292.x. [DOI] [PubMed] [Google Scholar]
  26. Eapen V., O'Neill J., Gurling H. M., Robertson M. M. Sex of parent transmission effect in Tourette's syndrome: evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect. Neurology. 1997 Apr;48(4):934–937. doi: 10.1212/wnl.48.4.934. [DOI] [PubMed] [Google Scholar]
  27. Elliott R., Baker S. C., Rogers R. D., O'Leary D. A., Paykel E. S., Frith C. D., Dolan R. J., Sahakian B. J. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol Med. 1997 Jul;27(4):931–942. doi: 10.1017/s0033291797005187. [DOI] [PubMed] [Google Scholar]
  28. Everitt B. J., Parkinson J. A., Olmstead M. C., Arroyo M., Robledo P., Robbins T. W. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann N Y Acad Sci. 1999 Jun 29;877:412–438. doi: 10.1111/j.1749-6632.1999.tb09280.x. [DOI] [PubMed] [Google Scholar]
  29. Everitt B. J., Parkinson J. A., Olmstead M. C., Arroyo M., Robledo P., Robbins T. W. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann N Y Acad Sci. 1999 Jun 29;877:412–438. doi: 10.1111/j.1749-6632.1999.tb09280.x. [DOI] [PubMed] [Google Scholar]
  30. Faber R., Trimble M. R. Electroconvulsive therapy in Parkinson's disease and other movement disorders. Mov Disord. 1991;6(4):293–303. doi: 10.1002/mds.870060405. [DOI] [PubMed] [Google Scholar]
  31. Folstein S. E., Chase G. A., Wahl W. E., McDonnell A. M., Folstein M. F. Huntington disease in Maryland: clinical aspects of racial variation. Am J Hum Genet. 1987 Aug;41(2):168–179. [PMC free article] [PubMed] [Google Scholar]
  32. Folstein S., Abbott M. H., Chase G. A., Jensen B. A., Folstein M. F. The association of affective disorder with Huntington's disease in a case series and in families. Psychol Med. 1983 Aug;13(3):537–542. doi: 10.1017/s0033291700047966. [DOI] [PubMed] [Google Scholar]
  33. George M. S., Robertson M. M., Costa D. C., Ell P. J., Trimble M. R., Pilowsky L., Verhoeff N. P. Dopamine receptor availability in Tourette's syndrome. Psychiatry Res. 1994 Dec;55(4):193–203. doi: 10.1016/0165-1781(95)91245-9. [DOI] [PubMed] [Google Scholar]
  34. Geschwind D. H., Loginov M., Stern J. M. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet. 1999 Sep;65(3):764–772. doi: 10.1086/302558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Giovannoni G., O'Sullivan J. D., Turner K., Manson A. J., Lees A. J. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):423–428. doi: 10.1136/jnnp.68.4.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Glatt S. L., Hubble J. P., Lyons K., Paolo A., Tröster A. I., Hassanein R. E., Koller W. C. Risk factors for dementia in Parkinson's disease: effect of education. Neuroepidemiology. 1996 Jan-Feb;15(1):20–25. doi: 10.1159/000109885. [DOI] [PubMed] [Google Scholar]
  37. Goetz C. G., Tanner C. M., Klawans H. L. Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry. 1982 Apr;139(4):494–497. doi: 10.1176/ajp.139.4.494. [DOI] [PubMed] [Google Scholar]
  38. Golbe L. I., Davis P. H., Schoenberg B. S., Duvoisin R. C. Prevalence and natural history of progressive supranuclear palsy. Neurology. 1988 Jul;38(7):1031–1034. doi: 10.1212/wnl.38.7.1031. [DOI] [PubMed] [Google Scholar]
  39. Goodwin F. K. Psychiatric side effects of levodopa in man. JAMA. 1971 Dec 27;218(13):1915–1920. [PubMed] [Google Scholar]
  40. Graybiel A. M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 1990 Jul;13(7):244–254. doi: 10.1016/0166-2236(90)90104-i. [DOI] [PubMed] [Google Scholar]
  41. Gurevich E. V., Himes J. W., Joyce J. N. Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja. J Pharmacol Exp Ther. 1999 Apr;289(1):587–598. [PubMed] [Google Scholar]
  42. Heinz A., Knable M. B., Wolf S. S., Jones D. W., Gorey J. G., Hyde T. M., Weinberger D. R. Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity. Neurology. 1998 Oct;51(4):1069–1074. doi: 10.1212/wnl.51.4.1069. [DOI] [PubMed] [Google Scholar]
  43. Hickie I., Scott E., Mitchell P., Wilhelm K., Austin M. P., Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995 Feb 1;37(3):151–160. doi: 10.1016/0006-3223(94)00174-2. [DOI] [PubMed] [Google Scholar]
  44. Hohol M. J., Guttmann C. R., Orav J., Mackin G. A., Kikinis R., Khoury S. J., Jolesz F. A., Weiner H. L. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol. 1997 Aug;54(8):1018–1025. doi: 10.1001/archneur.1997.00550200074013. [DOI] [PubMed] [Google Scholar]
  45. Huber S. J., Shuttleworth E. C., Paulson G. W. Dementia in Parkinson's disease. Arch Neurol. 1986 Oct;43(10):987–990. doi: 10.1001/archneur.1986.00520100009006. [DOI] [PubMed] [Google Scholar]
  46. Hynd G. W., Hern K. L., Novey E. S., Eliopulos D., Marshall R., Gonzalez J. J., Voeller K. K. Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol. 1993 Oct;8(4):339–347. doi: 10.1177/088307389300800409. [DOI] [PubMed] [Google Scholar]
  47. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbe L., Huber S., Koller W., Olanow C., Shoulson I. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990 Oct;40(10):1529–1534. doi: 10.1212/wnl.40.10.1529. [DOI] [PubMed] [Google Scholar]
  48. Jensen P., Fenger K., Bolwig T. G., Sørensen S. A. Crime in Huntington's disease: a study of registered offences among patients, relatives, and controls. J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):467–471. doi: 10.1136/jnnp.65.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Jentsch J. D., Taylor J. R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999 Oct;146(4):373–390. doi: 10.1007/pl00005483. [DOI] [PubMed] [Google Scholar]
  50. Joel D., Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience. 2000;96(3):451–474. doi: 10.1016/s0306-4522(99)00575-8. [DOI] [PubMed] [Google Scholar]
  51. Joyce J. N., Gurevich E. V. D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics. Ann N Y Acad Sci. 1999 Jun 29;877:595–613. doi: 10.1111/j.1749-6632.1999.tb09291.x. [DOI] [PubMed] [Google Scholar]
  52. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 1996 Apr;153(4):466–476. doi: 10.1176/ajp.153.4.466. [DOI] [PubMed] [Google Scholar]
  53. Kimura M., Matsumoto N. Neuronal activity in the basal ganglia. Functional implications. Adv Neurol. 1997;74:111–118. [PubMed] [Google Scholar]
  54. Koob G. F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 1997 Oct 3;278(5335):52–58. doi: 10.1126/science.278.5335.52. [DOI] [PubMed] [Google Scholar]
  55. Koob G. F. The role of the striatopallidal and extended amygdala systems in drug addiction. Ann N Y Acad Sci. 1999 Jun 29;877:445–460. doi: 10.1111/j.1749-6632.1999.tb09282.x. [DOI] [PubMed] [Google Scholar]
  56. Krüger S., Bräunig P., Höffler J., Shugar G., Börner I., Langkrär J. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci. 2000 Winter;12(1):16–24. doi: 10.1176/jnp.12.1.16. [DOI] [PubMed] [Google Scholar]
  57. König P. Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry. 1989 Feb 15;25(4):459–468. doi: 10.1016/0006-3223(89)90199-6. [DOI] [PubMed] [Google Scholar]
  58. Laasonen-Balk T., Kuikka J., Viinamäki H., Husso-Saastamoinen M., Lehtonen J., Tiihonen J. Striatal dopamine transporter density in major depression. Psychopharmacology (Berl) 1999 Jun;144(3):282–285. doi: 10.1007/s002130051005. [DOI] [PubMed] [Google Scholar]
  59. Lafer B., Renshaw P. F., Sachs G. S. Major depression and the basal ganglia. Psychiatr Clin North Am. 1997 Dec;20(4):885–896. doi: 10.1016/s0193-953x(05)70350-6. [DOI] [PubMed] [Google Scholar]
  60. Lauterbach E. C., Cummings J. L., Duffy J., Coffey C. E., Kaufer D., Lovell M., Malloy P., Reeve A., Royall D. R., Rummans T. A. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):249–266. doi: 10.1176/jnp.10.3.249. [DOI] [PubMed] [Google Scholar]
  61. Lieberman A. Managing the neuropsychiatric symptoms of Parkinson's disease. Neurology. 1998 Jun;50(6 Suppl 6):S33–S48. doi: 10.1212/wnl.50.6_suppl_6.s33. [DOI] [PubMed] [Google Scholar]
  62. Lou H. C., Henriksen L., Bruhn P., Børner H., Nielsen J. B. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol. 1989 Jan;46(1):48–52. doi: 10.1001/archneur.1989.00520370050018. [DOI] [PubMed] [Google Scholar]
  63. Luchins D. J., Metz J. T., Marks R. C., Cooper M. D. Basal ganglia regional glucose metabolism asymmetry during a catatonic episode. Biol Psychiatry. 1989 Nov;26(7):725–728. doi: 10.1016/0006-3223(89)90107-8. [DOI] [PubMed] [Google Scholar]
  64. Lund-Johansen M., Hugdahl K., Wester K. Cognitive function in patients with Parkinson's disease undergoing stereotaxic thalamotomy. J Neurol Neurosurg Psychiatry. 1996 May;60(5):564–571. doi: 10.1136/jnnp.60.5.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Malison R. T., McDougle C. J., van Dyck C. H., Scahill L., Baldwin R. M., Seibyl J. P., Price L. H., Leckman J. F., Innis R. B. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry. 1995 Sep;152(9):1359–1361. doi: 10.1176/ajp.152.9.1359. [DOI] [PubMed] [Google Scholar]
  66. Marder K., Tang M. X., Cote L., Stern Y., Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol. 1995 Jul;52(7):695–701. doi: 10.1001/archneur.1995.00540310069018. [DOI] [PubMed] [Google Scholar]
  67. Mayberg H. S., Solomon D. H. Depression in Parkinson's disease: a biochemical and organic viewpoint. Adv Neurol. 1995;65:49–60. [PubMed] [Google Scholar]
  68. Mayberg H. S., Starkstein S. E., Peyser C. E., Brandt J., Dannals R. F., Folstein S. E. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology. 1992 Sep;42(9):1791–1797. doi: 10.1212/wnl.42.9.1791. [DOI] [PubMed] [Google Scholar]
  69. Menza M. A., Robertson-Hoffman D. E., Bonapace A. S. Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry. 1993 Oct 1;34(7):465–470. doi: 10.1016/0006-3223(93)90237-8. [DOI] [PubMed] [Google Scholar]
  70. Meyer P., Bohnen N. I., Minoshima S., Koeppe R. A., Wernette K., Kilbourn M. R., Kuhl D. E., Frey K. A., Albin R. L. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology. 1999 Jul 22;53(2):371–374. doi: 10.1212/wnl.53.2.371. [DOI] [PubMed] [Google Scholar]
  71. Middleton F. A., Strick P. L. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science. 1994 Oct 21;266(5184):458–461. doi: 10.1126/science.7939688. [DOI] [PubMed] [Google Scholar]
  72. Middleton F. A., Strick P. L. New concepts about the organization of basal ganglia output. Adv Neurol. 1997;74:57–68. [PubMed] [Google Scholar]
  73. Mindham R. H. Psychiatric symptoms in Parkinsonism. J Neurol Neurosurg Psychiatry. 1970 Apr;33(2):188–191. doi: 10.1136/jnnp.33.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Mogenson G. J., Jones D. L., Yim C. Y. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol. 1980;14(2-3):69–97. doi: 10.1016/0301-0082(80)90018-0. [DOI] [PubMed] [Google Scholar]
  75. Nanji M. S., Nguyen V. T., Kawasoe J. H., Inui K., Endo F., Nakajima T., Anezaki T., Cox D. W. Haplotype and mutation analysis in Japanese patients with Wilson disease. Am J Hum Genet. 1997 Jun;60(6):1423–1429. doi: 10.1086/515459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Parent A., Cicchetti F. The current model of basal ganglia organization under scrutiny. Mov Disord. 1998 Mar;13(2):199–202. doi: 10.1002/mds.870130202. [DOI] [PubMed] [Google Scholar]
  77. Paulsen J. S., Ready R. E., Hamilton J. M., Mega M. S., Cummings J. L. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):310–314. doi: 10.1136/jnnp.71.3.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Peyser CE, Naimark D, Zuniga R, Jeste DV. Psychoses in Parkinson's Disease. Semin Clin Neuropsychiatry. 1998 Jan;3(1):41–50. [PubMed] [Google Scholar]
  79. Piven J., Arndt S., Bailey J., Andreasen N. Regional brain enlargement in autism: a magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry. 1996 Apr;35(4):530–536. doi: 10.1097/00004583-199604000-00020. [DOI] [PubMed] [Google Scholar]
  80. Rabins P. V., Pearlson G. D., Aylward E., Kumar A. J., Dowell K. Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry. 1991 May;148(5):617–620. doi: 10.1176/ajp.148.5.617. [DOI] [PubMed] [Google Scholar]
  81. Rauch S. L., Savage C. R. Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. Psychiatr Clin North Am. 1997 Dec;20(4):741–768. doi: 10.1016/s0193-953x(05)70343-9. [DOI] [PubMed] [Google Scholar]
  82. Rettig G. M., York M. K., Lai E. C., Jankovic J., Krauss J. K., Grossman R. G., Levin H. S. Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):326–336. doi: 10.1136/jnnp.69.3.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Robertson G. S., Matsumura H., Fibiger H. C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther. 1994 Nov;271(2):1058–1066. [PubMed] [Google Scholar]
  84. Robertson M. M. Annotation: Gilles de la Tourette syndrome--an update. J Child Psychol Psychiatry. 1994 May;35(4):597–611. doi: 10.1111/j.1469-7610.1994.tb01209.x. [DOI] [PubMed] [Google Scholar]
  85. Robertson M. M., Stern J. S. Tic disorders: new developments in Tourette syndrome and related disorders. Curr Opin Neurol. 1998 Aug;11(4):373–380. doi: 10.1097/00019052-199808000-00014. [DOI] [PubMed] [Google Scholar]
  86. Robertson M. M. Tourette syndrome, associated conditions and the complexities of treatment. Brain. 2000 Mar;123(Pt 3):425–462. doi: 10.1093/brain/123.3.425. [DOI] [PubMed] [Google Scholar]
  87. Robinson D., Wu H., Munne R. A., Ashtari M., Alvir J. M., Lerner G., Koreen A., Cole K., Bogerts B. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry. 1995 May;52(5):393–398. doi: 10.1001/archpsyc.1995.03950170067009. [DOI] [PubMed] [Google Scholar]
  88. Rogers D., Lees A. J., Smith E., Trimble M., Stern G. M. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. Brain. 1987 Jun;110(Pt 3):761–776. doi: 10.1093/brain/110.3.761. [DOI] [PubMed] [Google Scholar]
  89. Rogers M. A., Bradshaw J. L., Pantelis C., Phillips J. G. Frontostriatal deficits in unipolar major depression. Brain Res Bull. 1998 Nov 1;47(4):297–310. doi: 10.1016/s0361-9230(98)00126-9. [DOI] [PubMed] [Google Scholar]
  90. Rosenblatt A., Leroi I. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Psychosomatics. 2000 Jan-Feb;41(1):24–30. doi: 10.1016/S0033-3182(00)71170-4. [DOI] [PubMed] [Google Scholar]
  91. Samuel M., Caputo E., Brooks D. J., Schrag A., Scaravilli T., Branston N. M., Rothwell J. C., Marsden C. D., Thomas D. G., Lees A. J. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. Brain. 1998 Jan;121(Pt 1):59–75. doi: 10.1093/brain/121.1.59. [DOI] [PubMed] [Google Scholar]
  92. Scarone S., Colombo C., Livian S., Abbruzzese M., Ronchi P., Locatelli M., Scotti G., Smeraldi E. Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res. 1992 Aug;45(2):115–121. doi: 10.1016/0925-4927(92)90005-o. [DOI] [PubMed] [Google Scholar]
  93. Schoenfeld M., Myers R. H., Cupples L. A., Berkman B., Sax D. S., Clark E. Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry. 1984 Dec;47(12):1283–1287. doi: 10.1136/jnnp.47.12.1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Schultz W., Tremblay L., Hollerman J. R. Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology. 1998 Apr-May;37(4-5):421–429. doi: 10.1016/s0028-3908(98)00071-9. [DOI] [PubMed] [Google Scholar]
  95. Schwartz J. M., Stoessel P. W., Baxter L. R., Jr, Martin K. M., Phelps M. E. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1996 Feb;53(2):109–113. doi: 10.1001/archpsyc.1996.01830020023004. [DOI] [PubMed] [Google Scholar]
  96. Scott R., Gregory R., Hines N., Carroll C., Hyman N., Papanasstasiou V., Leather C., Rowe J., Silburn P., Aziz T. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain. 1998 Apr;121(Pt 4):659–675. doi: 10.1093/brain/121.4.659. [DOI] [PubMed] [Google Scholar]
  97. Sears L. L., Vest C., Mohamed S., Bailey J., Ranson B. J., Piven J. An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry. 1999 May;23(4):613–624. doi: 10.1016/s0278-5846(99)00020-2. [DOI] [PubMed] [Google Scholar]
  98. Serra-Mestres J., Ring H. A. Vulnerability to emotionally negative stimuli in Parkinson's disease: an investigation using the Emotional Stroop task. Neuropsychiatry Neuropsychol Behav Neurol. 1999 Jan;12(1):52–57. [PubMed] [Google Scholar]
  99. Sheppard D. M., Bradshaw J. L., Purcell R., Pantelis C. Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology? Clin Psychol Rev. 1999 Aug;19(5):531–552. doi: 10.1016/s0272-7358(98)00059-2. [DOI] [PubMed] [Google Scholar]
  100. Singer H. S., Hahn I. H., Moran T. H. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol. 1991 Oct;30(4):558–562. doi: 10.1002/ana.410300408. [DOI] [PubMed] [Google Scholar]
  101. Soares J. C., Mann J. J. The anatomy of mood disorders--review of structural neuroimaging studies. Biol Psychiatry. 1997 Jan 1;41(1):86–106. doi: 10.1016/s0006-3223(96)00006-6. [DOI] [PubMed] [Google Scholar]
  102. Starkstein S. E., Bolduc P. L., Mayberg H. S., Preziosi T. J., Robinson R. G. Cognitive impairments and depression in Parkinson's disease: a follow up study. J Neurol Neurosurg Psychiatry. 1990 Jul;53(7):597–602. doi: 10.1136/jnnp.53.7.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Starkstein S. E., Mayberg H. S., Leiguarda R., Preziosi T. J., Robinson R. G. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992 May;55(5):377–382. doi: 10.1136/jnnp.55.5.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Starkstein S. E., Preziosi T. J., Bolduc P. L., Robinson R. G. Depression in Parkinson's disease. J Nerv Ment Dis. 1990 Jan;178(1):27–31. doi: 10.1097/00005053-199001000-00005. [DOI] [PubMed] [Google Scholar]
  105. Stern Y., Marder K., Tang M. X., Mayeux R. Antecedent clinical features associated with dementia in Parkinson's disease. Neurology. 1993 Sep;43(9):1690–1692. doi: 10.1212/wnl.43.9.1690. [DOI] [PubMed] [Google Scholar]
  106. Stevens J. R., Livermore A., Jr Kindling of the mesolimbic dopamine system: animal model of psychosis. Neurology. 1978 Jan;28(1):36–46. doi: 10.1212/wnl.28.1.36. [DOI] [PubMed] [Google Scholar]
  107. Taylor A. E., Saint-Cyr J. A., Lang A. E., Kenny F. T. Parkinson's disease and depression. A critical re-evaluation. Brain. 1986 Apr;109(Pt 2):279–292. doi: 10.1093/brain/109.2.279. [DOI] [PubMed] [Google Scholar]
  108. Taylor A. E., Saint-Cyr J. A. The neuropsychology of Parkinson's disease. Brain Cogn. 1995 Aug;28(3):281–296. doi: 10.1006/brcg.1995.1258. [DOI] [PubMed] [Google Scholar]
  109. Trépanier L. L., Saint-Cyr J. A., Lozano A. M., Lang A. E. Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology. 1998 Jul;51(1):207–215. doi: 10.1212/wnl.51.1.207. [DOI] [PubMed] [Google Scholar]
  110. Tröster A. I., Fields J. A., Wilkinson S. B., Pahwa R., Miyawaki E., Lyons K. E., Koller W. C. Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology. 1997 Oct;49(4):1078–1083. doi: 10.1212/wnl.49.4.1078. [DOI] [PubMed] [Google Scholar]
  111. Turjanski N., Sawle G. V., Playford E. D., Weeks R., Lammerstma A. A., Lees A. J., Brooks D. J. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. J Neurol Neurosurg Psychiatry. 1994 Jun;57(6):688–692. doi: 10.1136/jnnp.57.6.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Volkow N. D., Fowler J. S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000 Mar;10(3):318–325. doi: 10.1093/cercor/10.3.318. [DOI] [PubMed] [Google Scholar]
  113. Vonsattel J. P., DiFiglia M. Huntington disease. J Neuropathol Exp Neurol. 1998 May;57(5):369–384. doi: 10.1097/00005072-199805000-00001. [DOI] [PubMed] [Google Scholar]
  114. Weinberger D. R., Lipska B. K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res. 1995 Aug 1;16(2):87–110. doi: 10.1016/0920-9964(95)00013-c. [DOI] [PubMed] [Google Scholar]
  115. Wolf S. S., Jones D. W., Knable M. B., Gorey J. G., Lee K. S., Hyde T. M., Coppola R., Weinberger D. R. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science. 1996 Aug 30;273(5279):1225–1227. doi: 10.1126/science.273.5279.1225. [DOI] [PubMed] [Google Scholar]
  116. Wolters E. C., Jansen E. N., Tuynman-Qua H. G., Bergmans P. L. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology. 1996 Oct;47(4):1085–1087. doi: 10.1212/wnl.47.4.1085. [DOI] [PubMed] [Google Scholar]
  117. Workman R. H., Jr, Orengo C. A., Bakey A. A., Molinari V. A., Kunik M. E. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1997 Fall;9(4):594–597. doi: 10.1176/jnp.9.4.594. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES